FNDC5 and obesity disorder: Previous studies are rather controversial and there is no general agreement about circulating irisin levels and their correlation with body mass and obesity-associated parameters [16, 17] and the beneficial effect of irisin on the treatment of obesity has been challenged by recent reports in obese animals and humans.